AB Biosciences, Inc.

AB Biosciences specializes in the design and manufacturing of specialized antibody molecules aimed at advancing biomedical research and the development of antibody-based therapies. The company focuses on providing essential tools for researchers, including control antibodies that validate the specificity of testing antibodies, and aglycosylated antibody therapeutics that enhance immune responses. Additionally, AB Biosciences offers expertise in various areas such as protein engineering, therapeutic antibody engineering, and neo CAR-T gene therapy. Their capabilities include extensive antibody mining, which supports the discovery and development of novel therapeutic options. The company is committed to supporting the scientific community with high-quality reagents and innovative solutions. This data was scraped from IndustryNet.com